CN1305525A - 吞噬的分析方法 - Google Patents

吞噬的分析方法 Download PDF

Info

Publication number
CN1305525A
CN1305525A CN99807222A CN99807222A CN1305525A CN 1305525 A CN1305525 A CN 1305525A CN 99807222 A CN99807222 A CN 99807222A CN 99807222 A CN99807222 A CN 99807222A CN 1305525 A CN1305525 A CN 1305525A
Authority
CN
China
Prior art keywords
cell
ced
compound
apoptosis
apoptotic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN99807222A
Other languages
English (en)
Chinese (zh)
Inventor
E·斯米茨
W·M·R·范克里金格
T·A·O·E·波格尔特
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Devgen NV
Original Assignee
Devgen NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9812660.0A external-priority patent/GB9812660D0/en
Priority claimed from GBGB9820816.8A external-priority patent/GB9820816D0/en
Application filed by Devgen NV filed Critical Devgen NV
Publication of CN1305525A publication Critical patent/CN1305525A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • C07K14/43536—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from worms
    • C07K14/4354—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from worms from nematodes
    • C07K14/43545—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from worms from nematodes from Caenorhabditis
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Toxicology (AREA)
  • Wood Science & Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Public Health (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
CN99807222A 1998-06-11 1999-06-10 吞噬的分析方法 Pending CN1305525A (zh)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB9812660.0 1998-06-11
GBGB9812660.0A GB9812660D0 (en) 1998-06-11 1998-06-11 Engulfment gene and uses thereof
GBGB9820816.8A GB9820816D0 (en) 1998-09-24 1998-09-24 Engulfment gene and uses thereof
GB9820816.8 1998-09-24

Publications (1)

Publication Number Publication Date
CN1305525A true CN1305525A (zh) 2001-07-25

Family

ID=26313846

Family Applications (1)

Application Number Title Priority Date Filing Date
CN99807222A Pending CN1305525A (zh) 1998-06-11 1999-06-10 吞噬的分析方法

Country Status (11)

Country Link
EP (1) EP1084242A2 (pt)
JP (1) JP2002517238A (pt)
KR (1) KR20010071453A (pt)
CN (1) CN1305525A (pt)
AU (1) AU4608499A (pt)
BR (1) BR9911097A (pt)
CA (1) CA2332993A1 (pt)
HU (1) HUP0102349A2 (pt)
IL (1) IL140016A0 (pt)
PL (1) PL345951A1 (pt)
WO (1) WO1999064586A2 (pt)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020004041A1 (en) * 1999-02-19 2002-01-10 Albert Matthew L. Methods for abrogating a cellular immune response
US6489535B1 (en) 1999-03-18 2002-12-03 The Board Of Trustees Of The Leland Stanford Junior University Non-mammalian transgenic animal having an adult onset neurodegenerative phenotype
US6316690B1 (en) 1999-08-04 2001-11-13 Tosk, Inc. Non-mammalian transgenic animal model for cellular proliferative diseases
US6365129B1 (en) 1999-08-04 2002-04-02 Tosk, Inc. Invivo high throughput toxicology screening method
US7615676B2 (en) 2001-11-30 2009-11-10 U.S. Department Of Veterans Affairs Transgenic screen and method for screening modulators of brain-derived neurotrophic factor (BDNF) production
US7491810B2 (en) * 2001-11-30 2009-02-17 U.S. Department Of Veterans Affairs Transgenic screen and method for screening modulators of brain-derived neurotrophic factor (BDNF) production
WO2018212612A1 (ko) * 2017-05-17 2018-11-22 울산과학기술원 자성 입자를 이용한 면역세포의 평가 방법 및 장치
KR102213080B1 (ko) * 2017-05-17 2021-02-08 울산과학기술원 자성 입자를 이용한 면역세포의 평가방법

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6232061B1 (en) * 1992-04-01 2001-05-15 Cambridge Neuroscience, Inc. Homology cloning

Also Published As

Publication number Publication date
CA2332993A1 (en) 1999-12-16
HUP0102349A2 (hu) 2001-10-28
JP2002517238A (ja) 2002-06-18
AU4608499A (en) 1999-12-30
EP1084242A2 (en) 2001-03-21
WO1999064586A3 (en) 2000-04-27
PL345951A1 (en) 2002-01-14
KR20010071453A (ko) 2001-07-28
IL140016A0 (en) 2002-02-10
WO1999064586A2 (en) 1999-12-16
BR9911097A (pt) 2001-02-13

Similar Documents

Publication Publication Date Title
CN108753824B (zh) 用于治疗视网膜营养不良的病毒载体
Santel et al. The Drosophila don juan (dj) gene encodes a novel sperm specific protein component characterized by an unusual domain of a repetitive amino acid motif
Gilleard et al. ELT-3: ACaenorhabditis elegansGATA Factor Expressed in the Embryonic Epidermis during Morphogenesis
Rogalski et al. The UNC-112 gene in Caenorhabditis elegans encodes a novel component of cell–matrix adhesion structures required for integrin localization in the muscle cell membrane
CN113683711A (zh) 靶向g-蛋白偶联受体的嵌合抗原受体及其用途
CN1305525A (zh) 吞噬的分析方法
CN111733174B (zh) 一种分离的核酸分子及其用途
CN115768890A (zh) 通过分子和物理启动对t细胞免疫疗法的热控制
CN110117818A (zh) 检测单基因突变的crispr高通量生物芯片
CN112203697A (zh) 编码氨基己糖苷酶alpha和beta亚基的双顺反子AAV载体及其用途
KR20220111294A (ko) 키메라 옵신 gpcr 단백질
KR20180057636A (ko) 반려 동물 치료용 aav-epo
CN112980819A (zh) 视网膜色素变性动物模型的构建方法及其应用
US12391948B2 (en) RNA-regulated fusion proteins and methods of their use
CN117545350A (zh) 不育禽类胚胎、其产生及用途
US20030157519A1 (en) Recombinant renilla reniformis system for bioluminescence resonance energy transfer
Harrison et al. A genetic analysis of the 63E-64A genomic region of Drosophila melanogaster: identification of mutations in a replication factor C subunit.
Yazawa et al. Development of gene transfer technology for black tiger shrimp, Penaeus monodon
CN106699882B (zh) 一种kap13-1基因在绵羊毛纤维细度鉴定中的应用
KR102570821B1 (ko) 재조합 바이러스 벡터 및 이를 이용한 약학 조성물
US20220330533A1 (en) Systems and methods for batch cultivation of non-transgenic heterogametes
CN113943749A (zh) 一种基于crispr基因编辑系统提高同源重组效率的方法
MXPA00011521A (en) Phagocytic assay method
US6465715B1 (en) Expression of DNA or proteins in C. elegans
US20030078406A1 (en) Methods and compositions for DRM, a secreted protein with cell growth inhibiting activity

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication